Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. [PDF]
Distenhreft JIQ +6 more
europepmc +1 more source
Qual o melhor tratamento da febre amarela?
33 p.Inclui proposiçõesExemplar originalmente digitalizado por U.S. National Library of Medicine https://archive.org/details/101464815.nlm.nih.govTese inaugural apresentada a Faculdade de Medicina da Bahia.
Novaes, Clementino Ribeiro de
core
[Vaccination coverage and delay in 2019 and 2020 birth cohorts: household survey in Cubatão, São Paulo State, Brazil]. [PDF]
Rozman LM +5 more
europepmc +1 more source
Yellow fever beyond the Amazon: surveillance challenges and the role of <i>Callithrix</i> spp. in sylvatic cycles in Brazil. [PDF]
Drumond BP, Nogueira ML, Vasilakis N.
europepmc +1 more source
[Evidence map of chikungunya treatmentsMapa de la evidencia sobre el tratamiento del chikunguña]. [PDF]
de Castro AS +7 more
europepmc +1 more source
[Microplanning as a tool to strengthen the National Immunization Program in BrazilLa microplanificación como herramienta para fortalecer el Programa Nacional de Inmunizaciones en Brasil]. [PDF]
Araújo ACM +6 more
europepmc +1 more source
[The Antonio Gonçalves Peryassú mosquito collection at the Museu Nacional, in Rio de Janeiro: retrieving the memory of lost heritage]. [PDF]
Lourenço-de-Oliveira R, Lourenço FDS.
europepmc +1 more source
Discrepancy between official records of the Brazilian National Immunization Program Information System and the household survey about vaccination coverage in Cubatão, São Paulo: cross-sectional study, 2023. [PDF]
Rozman LM +3 more
europepmc +1 more source
Yellow fever in Latin America and the escalating risks in a changing eco-epidemiological landscape: a review. [PDF]
Ortiz-Prado E +11 more
europepmc +1 more source
Risk of reintroduction of vaccine-preventable diseases in the state of São Paulo, Brazil. [PDF]
Santana JES +7 more
europepmc +1 more source

